Establishment Labs Holdings Inc
NASDAQ:ESTA
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
22.88
59.86
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Establishment Labs Holdings Inc
Establishment Labs Holdings Inc
Cost of Revenue
Establishment Labs Holdings Inc
Cost of Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Establishment Labs Holdings Inc
NASDAQ:ESTA
|
Cost of Revenue
-$53.5m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
N/A
|
|
Establishment Labs Holdings Inc
Glance View
Establishment Labs Holdings, Inc. is a technology company, which engages in the design, development, manufacture, and marketing of silicone breast implants. The company is headquartered in Alajuela, Alajuela and currently employs 746 full-time employees. The company went IPO on 2018-07-19. The firm is engaged in the designing, developing, manufacturing and marketing of product portfolio consisting of silicone-filled breast and body shaping implants. Its line of silicone gel-filled breast implants, branded as MotivaImplants, is the centerpiece of its MotivaImagine medical technology platform. The Company’s MotivaImplants are sold in over 60 countries.
See Also
What is Establishment Labs Holdings Inc's Cost of Revenue?
Cost of Revenue
-53.5m
USD
Based on the financial report for Sep 30, 2024, Establishment Labs Holdings Inc's Cost of Revenue amounts to -53.5m USD.
What is Establishment Labs Holdings Inc's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-10%
Over the last year, the Cost of Revenue growth was 15%. The average annual Cost of Revenue growth rates for Establishment Labs Holdings Inc have been -8% over the past three years , -10% over the past five years .
You don't have any saved screeners yet
